دورية أكاديمية
أعرض في EDS

Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.

التفاصيل البيبلوغرافية
العنوان: Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.
المؤلفون: Zhu Q; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China., Chen Z; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China., Paul PK; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.; Department of Pharmacy, Gono Bishwabidyalay (University), Mirzanagar Savar, Dhaka 1344, Bangladesh., Lu Y; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.; Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China., Wu W; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.; Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China., Qi J; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.; Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China.
المصدر: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2021 Aug; Vol. 11 (8), pp. 2416-2448. Date of Electronic Publication: 2021 Apr 29.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam] : Elsevier, 2011-
مستخلص: Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules than small molecular drugs due to their high selectivity and efficacy, but fewer side effects. Owing to the poor stability and limited permeability through gastrointestinal (GI) tract and epithelia, the therapeutic PPs are usually administered by parenteral route. Given the big demand for oral administration in clinical use, a variety of researches focused on developing new technologies to overcome GI barriers of PPs, such as enteric coating, enzyme inhibitors, permeation enhancers, nanoparticles, as well as intestinal microdevices. Some new technologies have been developed under clinical trials and even on the market. This review summarizes the history, the physiological barriers and the overcoming approaches, current clinical and preclinical technologies, and future prospects of oral delivery of PPs.
Competing Interests: The authors have no conflicts of interest to declare.
(© 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.)
References: ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9916-9928. (PMID: 29504398)
AAPS PharmSciTech. 2017 May;18(4):1277-1287. (PMID: 27480441)
J Control Release. 2010 Jan 25;141(2):177-82. (PMID: 19761807)
Drug Deliv. 2016 Jul;23(6):2015-25. (PMID: 26203690)
Vaccine. 2018 Aug 9;36(33):4973-4978. (PMID: 30017142)
Pharmaceutics. 2019 Aug 19;11(8):. (PMID: 31430872)
Drug Discov Today. 2005 Sep 1;10(17):1145-57. (PMID: 16182207)
Nanoscale. 2017 Oct 19;9(40):15252-15277. (PMID: 28984885)
Pharmaceutics. 2019 Jun 26;11(7):. (PMID: 31248025)
Adv Drug Deliv Rev. 2005 Nov 3;57(11):1569-82. (PMID: 16176846)
Eur J Pharm Biopharm. 2015 Oct;96:447-53. (PMID: 25712487)
Eur J Pharm Biopharm. 2011 Feb;77(2):216-24. (PMID: 21147220)
Crit Rev Ther Drug Carrier Syst. 2007;24(1):63-92. (PMID: 17430100)
Gut. 1988 Aug;29(8):1035-41. (PMID: 3410329)
Int J Pharm. 2006 Dec 11;327(1-2):153-9. (PMID: 16935443)
PLoS One. 2013 Apr 09;8(4):e59524. (PMID: 23593142)
Biopolymers. 2016 Jan;106(1):89-100. (PMID: 26566734)
Mol Pharm. 2019 Dec 2;16(12):5013-5024. (PMID: 31638827)
AAPS PharmSciTech. 2019 May 20;20(5):190. (PMID: 31111296)
Drug Discov Today. 2011 Nov;16(21-22):991-7. (PMID: 21683153)
Expert Opin Drug Deliv. 2018 Aug;15(8):805-820. (PMID: 30025216)
Drug Discov Today. 2014 Jul;19(7):898-904. (PMID: 24631680)
J Control Release. 2000 Mar 1;65(1-2):19-29. (PMID: 10699266)
Int J Pharm. 2014 Jan 2;460(1-2):119-30. (PMID: 24275447)
Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):61-95. (PMID: 7600588)
J Pept Res. 1999 May;53(5):530-41. (PMID: 10424348)
Curr Opin Cell Biol. 1993 Oct;5(5):772-8. (PMID: 8240820)
Adv Drug Deliv Rev. 2018 Jan 15;124:3-15. (PMID: 28970050)
J Diabetes Sci Technol. 2014 May;8(3):551-9. (PMID: 24876619)
Adv Drug Deliv Rev. 2018 Oct;135:3-38. (PMID: 30217519)
Adv Drug Deliv Rev. 2018 Jan 15;124:150-163. (PMID: 28989056)
J Control Release. 2015 Jan 10;197:48-57. (PMID: 25449804)
Nat Rev Drug Discov. 2019 Jan;18(1):19-40. (PMID: 30498202)
Int J Pharm. 2013 Apr 15;447(1-2):75-93. (PMID: 23428883)
J Control Release. 2004 Mar 24;95(3):589-99. (PMID: 15023469)
Int J Nanomedicine. 2012;7:3333-9. (PMID: 22848162)
FEBS Lett. 2014 Jun 27;588(14):2177-84. (PMID: 24846139)
Int J Pharm. 2017 Sep 15;530(1-2):279-290. (PMID: 28764982)
Pharmaceutics. 2019 Feb 13;11(2):. (PMID: 30781867)
Biochim Biophys Acta. 2002 Sep 19;1572(2-3):364-86. (PMID: 12223280)
J Clin Invest. 1995 Aug;96(2):710-20. (PMID: 7635964)
Expert Opin Drug Deliv. 2014 Aug;11(8):1323-35. (PMID: 24816134)
J Control Release. 2013 Dec 28;172(3):753-62. (PMID: 24035976)
J Pharm Sci. 2017 Dec;106(12):3465-3473. (PMID: 28778425)
J Control Release. 2018 Oct 10;287:167-176. (PMID: 30145135)
AAPS J. 2015 Jan;17(1):134-43. (PMID: 25366889)
World J Gastroenterol. 2010 Nov 21;16(43):5496-501. (PMID: 21086570)
ACS Biomater Sci Eng. 2023 Jun 12;9(6):2838-2845. (PMID: 37303163)
J Control Release. 2013 Dec 28;172(3):872-8. (PMID: 24140721)
Int J Pharm. 2020 Sep 25;587:119682. (PMID: 32717284)
Eur J Pharm Biopharm. 2018 Feb;123:84-94. (PMID: 29175551)
Pharm Res. 2002 Apr;19(4):391-5. (PMID: 12033369)
J Control Release. 2019 Dec 10;315:206-213. (PMID: 31672623)
Eur J Pharm Biopharm. 2019 Jun;139:168-176. (PMID: 30940541)
J Clin Endocrinol Metab. 2012 Jul;97(7):2362-9. (PMID: 22539587)
Int J Pharm. 2019 Sep 10;568:118508. (PMID: 31299337)
Osteoarthritis Cartilage. 2010 Feb;18(2):150-9. (PMID: 19747581)
Biomaterials. 2013 May;34(14):3667-77. (PMID: 23419643)
Expert Opin Drug Deliv. 2012 Oct;9(10):1289-304. (PMID: 22897647)
J Pharm Pharmacol. 2016 Sep;68(9):1093-108. (PMID: 27364922)
Int J Pharm. 2002 Oct 24;247(1-2):47-55. (PMID: 12429484)
Pharm Res. 1997 Dec;14(12):1830-4. (PMID: 9453076)
Drug Dev Ind Pharm. 2017 May;43(5):862-870. (PMID: 27489129)
Expert Opin Drug Deliv. 2018 Aug;15(8):787-804. (PMID: 30025212)
Endocrinol Jpn. 1985 Aug;32(4):547-57. (PMID: 3936702)
Eur J Pharm Sci. 2017 Jan 15;97:151-157. (PMID: 27866015)
Biotechnol Adv. 2019 Nov 15;37(7):107412. (PMID: 31254660)
Nat Med. 2019 Oct;25(10):1471-1472. (PMID: 31591600)
Curr Opin Biotechnol. 2019 Dec;60:159-167. (PMID: 30861476)
Int J Pharm. 2015 Dec 30;496(2):993-1005. (PMID: 26541299)
Nanomedicine (Lond). 2018 Oct;13(19):2527-2544. (PMID: 30338724)
Am J Gastroenterol. 1997 Jan;92(1):114-8. (PMID: 8995949)
Eur J Pharm Sci. 2020 Apr 30;147:105280. (PMID: 32109493)
Mater Sci Eng C Mater Biol Appl. 2018 Feb 1;83:233-246. (PMID: 29208283)
Biomaterials. 2010 Oct;31(30):7738-47. (PMID: 20656343)
Adv Drug Deliv Rev. 2004 Apr 19;56(6):795-807. (PMID: 15063590)
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):355-366. (PMID: 27155131)
J Control Release. 2009 Apr 2;135(1):51-9. (PMID: 19168100)
J Pharm Sci. 1994 Mar;83(3):444-6. (PMID: 8207699)
Drug Deliv. 2019 Dec;26(1):216-225. (PMID: 30843439)
Recent Pat Drug Deliv Formul. 2009 Jun;3(2):94-104. (PMID: 19519570)
Carbohydr Polym. 2018 Jul 1;191:191-197. (PMID: 29661309)
Adv Drug Deliv Rev. 2009 Feb 27;61(2):158-71. (PMID: 19133304)
Pharm Dev Technol. 2007;12(5):505-23. (PMID: 17963151)
Curr Pharm Des. 2010;16(28):3185-203. (PMID: 20687878)
J Control Release. 2020 Nov 10;327:161-173. (PMID: 32771477)
Bioconjug Chem. 2008 Nov 19;19(11):2253-9. (PMID: 18834167)
Biochem Biophys Res Commun. 1984 Jun 15;121(2):521-9. (PMID: 6732822)
Eur J Pharm Biopharm. 2018 Jul;128:98-106. (PMID: 29653178)
Front Biosci. 2001 Oct 01;6:D1321-57. (PMID: 11578958)
Expert Opin Biol Ther. 2004 Jun;4(6):881-7. (PMID: 15174970)
Int J Pharm. 2004 Jun 11;277(1-2):91-7. (PMID: 15158972)
Biomaterials. 2009 Oct;30(29):5691-700. (PMID: 19615735)
Nat Rev Drug Discov. 2015 Nov;14(11):781-803. (PMID: 26471369)
ACS Appl Mater Interfaces. 2015 Jul 22;7(28):15430-41. (PMID: 26111015)
Int J Mol Sci. 2019 Mar 12;20(5):. (PMID: 30871103)
Curr Drug Metab. 2012 May 1;13(4):418-28. (PMID: 22443536)
ACS Appl Mater Interfaces. 2018 Dec 26;10(51):44354-44367. (PMID: 30525379)
J Control Release. 2017 Sep 28;262:273-283. (PMID: 28774842)
J Control Release. 2019 Aug 10;307:64-75. (PMID: 31207275)
J Diabetes Sci Technol. 2014 May;8(3):458-65. (PMID: 24876606)
J Biomed Mater Res B Appl Biomater. 2009 Jan;88(1):41-8. (PMID: 18946870)
Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438. (PMID: 30144240)
J Control Release. 2008 Jul 2;129(1):41-8. (PMID: 18474405)
J Control Release. 2018 Apr 10;275:92-106. (PMID: 29454741)
J Control Release. 2007 Jul 31;120(3):195-204. (PMID: 17586081)
Mol Pharm. 2015 Mar 2;12(3):966-73. (PMID: 25612507)
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7296-7301. (PMID: 29941553)
Ther Deliv. 2011 Dec;2(12):1575-93. (PMID: 22833983)
Mol Pharm. 2013 Nov 4;10(11):4159-67. (PMID: 24006937)
Nanomedicine. 2016 Oct;12(7):1863-1871. (PMID: 27112308)
J Cell Biol. 1999 Oct 4;147(1):195-204. (PMID: 10508866)
J Control Release. 2004 Jul 23;98(1):37-45. (PMID: 15245887)
Int J Biochem Mol Biol. 2012;3(3):290-301. (PMID: 23097745)
Adv Drug Deliv Rev. 2018 Jan 15;124:125-139. (PMID: 28882703)
Eur J Pharm Biopharm. 2019 Jun;139:23-32. (PMID: 30851353)
Saudi Pharm J. 2016 Jul;24(4):413-28. (PMID: 27330372)
Int J Pharm. 2014 Oct 1;473(1-2):627-35. (PMID: 25089510)
J Diabetes Sci Technol. 2017 Jul;11(4):825-832. (PMID: 28654313)
Biomaterials. 2012 Feb;33(5):1573-82. (PMID: 22093292)
Eur J Pharm Sci. 2012 Apr 11;45(5):632-8. (PMID: 22248882)
Int J Biol Macromol. 2020 Apr 15;149:976-988. (PMID: 32018009)
Biochim Biophys Acta. 1997 Sep 4;1328(2):261-72. (PMID: 9315622)
Mol Pharm. 2015 Nov 2;12(11):3816-28. (PMID: 26394158)
Curr Drug Metab. 2014;15(6):599-619. (PMID: 25255874)
Int J Nanomedicine. 2013;8:23-32. (PMID: 23293517)
Drug Discov Today Technol. 2005 Spring;2(1):75-81. (PMID: 24981758)
Int J Biol Macromol. 2019 Apr 1;126:141-150. (PMID: 30586591)
Eur J Pharm Sci. 2011 Apr 18;42(5):445-51. (PMID: 21182939)
Int J Pharm. 2014 Dec 30;477(1-2):390-8. (PMID: 25455781)
Adv Drug Deliv Rev. 2002 Jun 17;54(4):459-76. (PMID: 12052709)
J Control Release. 2018 Jan 28;270:184-202. (PMID: 29203415)
Carbohydr Polym. 2020 May 15;236:115972. (PMID: 32172827)
Nanomedicine. 2016 Nov;12(8):2241-2250. (PMID: 27339784)
Eur J Pharm Sci. 2019 Oct 1;138:105019. (PMID: 31374253)
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13313-8. (PMID: 25157174)
Clin Transl Sci. 2019 May;12(3):276-282. (PMID: 30592549)
Int J Pharm. 2013 Jan 30;441(1-2):693-700. (PMID: 23089580)
Expert Opin Drug Deliv. 2014 Dec;11(12):1955-67. (PMID: 25078141)
Anal Chem. 2018 Sep 18;90(18):10897-10902. (PMID: 30152690)
Eur J Pharm Biopharm. 2009 Sep;73(1):16-24. (PMID: 19409989)
J Pharm Sci. 2018 May;107(5):1269-1281. (PMID: 29274822)
Biologicals. 2011 May;39(3):181-8. (PMID: 21550265)
Pharm Res. 1997 Dec;14(12):1772-9. (PMID: 9453067)
Adv Drug Deliv Rev. 1997 Sep 15;27(2-3):235-256. (PMID: 10837560)
Adv Healthc Mater. 2019 Jun;8(12):e1801123. (PMID: 30485708)
Nanomedicine. 2014 Jan;10(1):167-76. (PMID: 23891617)
J Control Release. 2020 Jun 10;322:602-609. (PMID: 32201308)
FEBS Lett. 1995 Sep 11;371(3):283-6. (PMID: 7556611)
Sci Rep. 2019 Apr 15;9(1):6106. (PMID: 30988384)
Drug Deliv. 2016 Sep;23(7):2419-2427. (PMID: 25594571)
Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1293-303. (PMID: 22686526)
Biomaterials. 2010 Apr;31(12):3347-56. (PMID: 20116843)
Adv Mater. 2012 Jul 24;24(28):3887-94. (PMID: 22988559)
J Control Release. 2006 Dec 1;116(3):337-45. (PMID: 17097180)
Biomater Sci. 2019 Jun 25;7(7):2934-2950. (PMID: 31094367)
Eur J Pharm Biopharm. 2012 Jun;81(2):265-72. (PMID: 22369880)
Mol Pharmacol. 2003 Dec;64(6):1530-40. (PMID: 14645684)
Int J Pharm. 2008 Feb 12;349(1-2):226-33. (PMID: 17825506)
J Drug Target. 2020 Apr;28(4):339-355. (PMID: 31575296)
FEBS Lett. 1976 Feb 1;62(1):60-3. (PMID: 129340)
Adv Drug Deliv Rev. 2007 Jul 10;59(6):478-90. (PMID: 17543416)
Nanomedicine. 2015 Oct;11(7):1689-94. (PMID: 26051651)
Adv Colloid Interface Sci. 2018 Feb;252:69-82. (PMID: 29329667)
Br Med J. 1923 Dec 22;2(3286):1204-5. (PMID: 20771392)
Int J Pharm. 2003 Jul 24;260(2):229-37. (PMID: 12842342)
J Pharm Pharm Sci. 2008;11(1):59-66. (PMID: 18445364)
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26. (PMID: 11259830)
Pharm Res. 1991 Jun;8(6):721-7. (PMID: 2062801)
Protein Pept Lett. 2014;21(11):1102-20. (PMID: 25106908)
Nat Biotechnol. 2007 Oct;25(10):1159-64. (PMID: 17873867)
Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35. (PMID: 20863829)
AAPS J. 2016 Jul;18(4):830-43. (PMID: 27184579)
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):821-834. (PMID: 28650209)
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4331-6. (PMID: 19246373)
Nanomedicine (Lond). 2012 Sep;7(9):1311-37. (PMID: 22583576)
Colloids Surf B Biointerfaces. 2011 Jan 1;82(1):118-25. (PMID: 20843665)
Int J Pharm. 2018 Dec 1;552(1-2):171-179. (PMID: 30261214)
Chem Rev. 2017 May 24;117(10):7132-7189. (PMID: 28125212)
Nano Lett. 2016 Nov 9;16(11):7176-7182. (PMID: 27700115)
Aliment Pharmacol Ther. 2013 Jan;37(2):252-62. (PMID: 23163616)
J Mater Chem B. 2016 May 7;4(17):2864-2873. (PMID: 32262964)
Biomaterials. 2007 Feb;28(6):1258-66. (PMID: 17118443)
Nanomedicine (Lond). 2016 Dec;11(24):3223-3235. (PMID: 27830630)
Int J Nanomedicine. 2007;2(4):743-9. (PMID: 18203440)
Carbohydr Polym. 2017 Sep 1;171:242-251. (PMID: 28578960)
Gastroenterology. 1962 Sep;43:326-9. (PMID: 13893646)
Biol Pharm Bull. 2018;41(2):239-246. (PMID: 29386483)
Int J Pharm. 2019 Mar 10;558:380-387. (PMID: 30664995)
Annu Rev Physiol. 1995;57:565-83. (PMID: 7778878)
Int J Pharm. 2019 Oct 5;569:118584. (PMID: 31376466)
Curr Drug Deliv. 2005 Apr;2(2):191-7. (PMID: 16305420)
Eur J Pharm Biopharm. 2010 Oct;76(2):159-69. (PMID: 20655382)
J Pharm Pharmacol. 2012 Feb;64(2):218-27. (PMID: 22221097)
Ann Biomed Eng. 2016 Jun;44(6):1993-2007. (PMID: 26864536)
Horm Res. 1982 Jul-Aug;16(4):249-56. (PMID: 6751980)
Pharmaceutics. 2019 Mar 19;11(3):. (PMID: 30893852)
Int J Biol Macromol. 2014 Feb;63:15-20. (PMID: 24444886)
Nutr Res Rev. 2014 Dec;27(2):308-29. (PMID: 25623084)
J Diabetes Sci Technol. 2009 Nov 01;3(6):1451-9. (PMID: 20144401)
Acta Crystallogr D Biol Crystallogr. 1995 Jan 1;51(Pt 1):48-59. (PMID: 15299335)
Int J Pharm. 2020 Nov 15;589:119842. (PMID: 32890655)
Int J Inflam. 2010 Sep 19;2010:823710. (PMID: 21188221)
Nat Med. 2019 Oct;25(10):1512-1518. (PMID: 31591601)
Toxicology. 2010 Dec 30;278(3):256-67. (PMID: 20600548)
Physiol Res. 2018 Oct 30;67(Suppl 2):S267-S279. (PMID: 30379549)
Ther Deliv. 2015;6(8):973-87. (PMID: 26272222)
Br J Clin Pharmacol. 2012 Dec;74(6):911-9. (PMID: 22452339)
Adv Drug Deliv Rev. 2016 Jun 1;101:108-121. (PMID: 26826437)
Curr Opin Pharmacol. 2017 Oct;36:58-65. (PMID: 28850875)
Chem Rev. 2017 May 24;117(10):6633-6635. (PMID: 28535681)
Diabetologia. 2015 Jun;58(6):1175-82. (PMID: 25725624)
Int J Biol Macromol. 2020 May 1;150:528-535. (PMID: 32057854)
Adv Drug Deliv Rev. 2019 Mar 1;142:91-101. (PMID: 29981355)
Adv Drug Deliv Rev. 2012 May 1;64(6):557-70. (PMID: 22212900)
Food Chem. 2018 Jan 15;239:486-494. (PMID: 28873595)
Drug Discov Today Technol. 2012 Summer;9(2):e71-e174. (PMID: 24064271)
Int J Nanomedicine. 2007;2(4):595-607. (PMID: 18203427)
Thromb J. 2006 May 10;4:6. (PMID: 16686945)
J Control Release. 2009 Mar 4;134(2):98-102. (PMID: 19095021)
Am J Physiol. 1995 Oct;269(4 Pt 1):G467-75. (PMID: 7485497)
J Mol Biol. 2011 May 6;408(3):514-28. (PMID: 21377472)
Adv Drug Deliv Rev. 2013 Oct;65(10):1331-9. (PMID: 22921839)
Science. 2019 Feb 8;363(6427):611-615. (PMID: 30733413)
Eur J Pharm Biopharm. 2016 Dec;109:113-121. (PMID: 27693677)
Nat Biomed Eng. 2020 Jan;4(1):84-96. (PMID: 31686002)
ACS Biomater Sci Eng. 2019 Jul 8;5(7):3645-3653. (PMID: 33405745)
Nat Chem. 2011 Jun 23;3(7):509-24. (PMID: 21697871)
J Pharm Sci. 2011 Aug;100(8):3251-3259. (PMID: 21465487)
Pharm Res. 1990 Feb;7(2):167-9. (PMID: 2137911)
Adv Healthc Mater. 2016 Nov;5(21):2745-2750. (PMID: 27717163)
Med Res Rev. 2019 Nov;39(6):2153-2171. (PMID: 31006878)
JPEN J Parenter Enteral Nutr. 1999 Jan-Feb;23(1):19-23. (PMID: 9888413)
Sci Transl Med. 2013 Nov 27;5(213):213ra167. (PMID: 24285486)
Adv Mater. 2020 Apr;32(13):e1901935. (PMID: 31222910)
Pharm Res. 2017 Jan;34(1):229-242. (PMID: 27800571)
Acta Biomater. 2012 Feb;8(2):653-8. (PMID: 21982846)
Expert Opin Drug Deliv. 2018 Jun;15(6):541-543. (PMID: 29708770)
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):277-319. (PMID: 27320643)
Adv Drug Deliv Rev. 2012 May 1;64(6):523-30. (PMID: 21827802)
Colloids Surf B Biointerfaces. 2015 Sep 1;133:120-39. (PMID: 26094145)
J Diabetes Sci Technol. 2009 May 01;3(3):568-84. (PMID: 20144297)
J Drug Target. 2012 Jul;20(6):481-501. (PMID: 22632037)
J Biol Chem. 2001 Jun 1;276(22):19160-5. (PMID: 11278543)
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. (PMID: 27848962)
Nature. 1961 Apr 15;190:263-4. (PMID: 13785784)
Int J Pharm. 2018 Aug 25;547(1-2):265-273. (PMID: 29800739)
J Mol Med (Berl). 2017 Sep;95(9):927-934. (PMID: 28707083)
Trends Biotechnol. 2009 Nov;27(11):628-35. (PMID: 19766335)
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):223-241. (PMID: 26921819)
J Control Release. 2014 Nov 10;193:241-56. (PMID: 24801249)
Acta Pharm Sin B. 2018 Jan;8(1):97-105. (PMID: 29872626)
Bioorg Med Chem. 2018 Mar 15;26(6):1135-1150. (PMID: 29295762)
Adv Healthc Mater. 2017 Aug;6(15):. (PMID: 28337858)
Eur J Pharmacol. 2018 Jan 5;818:211-220. (PMID: 29079360)
Expert Opin Drug Deliv. 2018 Mar;15(3):223-233. (PMID: 29111841)
J Biol Chem. 1994 Apr 8;269(14):10444-50. (PMID: 8144628)
Eur J Pharm Biopharm. 2014 Apr;86(3):544-51. (PMID: 24384069)
J Control Release. 2005 Feb 16;102(3):525-38. (PMID: 15681076)
Int J Pharm. 2009 Jan 5;365(1-2):121-30. (PMID: 18832018)
Adv Drug Deliv Rev. 2020;165-166:41-59. (PMID: 31837356)
Acta Pharm. 2017 Jun 27;67(2):149-168. (PMID: 28590908)
Vaccine. 2003 Jan 17;21(5-6):341-6. (PMID: 12531630)
Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:333-40. (PMID: 25491995)
Sci Transl Med. 2017 Mar 8;9(380):. (PMID: 28275153)
Pharm Res. 2000 Jan;17(1):27-31. (PMID: 10714604)
Mol Pharm. 2012 May 7;9(5):1271-9. (PMID: 22462641)
Dig Dis Sci. 2007 Jan;52(1):1-17. (PMID: 17205399)
Clin Pharmacol Drug Dev. 2020 Jan;9(1):74-86. (PMID: 31392840)
Clin Ther. 2012 Dec;34(12):2333-8. (PMID: 23195963)
J Control Release. 2016 Sep 28;238:176-185. (PMID: 27480450)
Acta Pharm Sin B. 2019 Jan;9(1):36-48. (PMID: 30766776)
Nat Rev Drug Discov. 2020 Apr;19(4):277-289. (PMID: 31848464)
Drugs. 2017 Nov;77(17):1833-1855. (PMID: 29076109)
J Pharm Sci. 2015 Sep;104(9):2855-63. (PMID: 25411065)
Vaccine. 1994 Nov;12(14):1270-4. (PMID: 7856290)
J Control Release. 2018 Feb 28;272:29-38. (PMID: 29305112)
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):193-195. (PMID: 27865345)
Pharm Res. 1999 Aug;16(8):1233-9. (PMID: 10468025)
Eur J Pharm Biopharm. 2014 Sep;88(1):194-206. (PMID: 24769065)
ACS Omega. 2020 Jul 17;5(29):18185-18197. (PMID: 32743193)
J Control Release. 2003 Mar 26;88(3):369-80. (PMID: 12644363)
Expert Opin Drug Deliv. 2017 Jan;14(1):23-36. (PMID: 27351299)
ACS Appl Mater Interfaces. 2017 Dec 13;9(49):42492-42502. (PMID: 29148702)
Adv Mater. 2019 Mar;31(10):e1805730. (PMID: 30614561)
Am J Anat. 1974 Dec;141(4):537-61. (PMID: 4440635)
J Pharm Sci. 2014 Dec;103(12):3985-3993. (PMID: 25332052)
J Pharm Pharmacol. 1992 Jul;44(7):555-9. (PMID: 1357133)
J Drug Target. 2017 Aug;25(7):608-615. (PMID: 28266884)
Mol Pharm. 2015 Dec 7;12(12):4405-13. (PMID: 26568266)
J Pharm Sci. 2015 Feb;104(2):362-7. (PMID: 25250829)
Biomaterials. 2018 Jan;151:13-23. (PMID: 29055774)
Drug Discov Today. 2006 Oct;11(19-20):905-10. (PMID: 16997140)
Scand J Infect Dis. 2011 May;43(5):386-8. (PMID: 21198337)
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):256-276. (PMID: 27496705)
PLoS One. 2013;8(1):e55143. (PMID: 23383086)
J Drug Target. 2013 Apr;21(3):291-299. (PMID: 30952177)
Biomaterials. 2012 Mar;33(9):2801-11. (PMID: 22243802)
Int J Pharm. 1999 Aug 20;185(2):129-88. (PMID: 10460913)
Eur J Pharm Biopharm. 2018 Oct;131:8-24. (PMID: 30006246)
Int J Pharm. 2019 Sep 10;568:118505. (PMID: 31306712)
ACS Macro Lett. 2017 Feb 21;6(2):161-164. (PMID: 35632886)
J Pharm Sci. 2001 Jan;90(1):38-46. (PMID: 11064377)
Gastroenterology. 1974 Feb;66(2):189-203. (PMID: 4810912)
Int J Pharm. 2005 Apr 27;294(1-2):247-59. (PMID: 15814248)
Adv Drug Deliv Rev. 2019 Nov - Dec;151-152:72-93. (PMID: 31626825)
Acta Biomater. 2016 Feb;31:288-300. (PMID: 26685755)
J Mater Chem B. 2016 Jun 14;4(22):4040-4048. (PMID: 32263103)
Science. 1981 Apr 24;212(4493):471-2. (PMID: 6259737)
Drug Discov Today. 2003 Jul 15;8(14):607-8. (PMID: 12867138)
Biol Pharm Bull. 2015;38(2):208-17. (PMID: 25747979)
J Pharm Sci. 2016 Feb;105(2):697-704. (PMID: 26414114)
Am J Pathol. 2012 Feb;180(2):608-15. (PMID: 22119716)
Dig Dis Sci. 1993 Nov;38(11):1989-93. (PMID: 8223071)
Int J Pharm. 2012 Sep 15;434(1-2):315-24. (PMID: 22692074)
Vaccine. 2011 Jul 18;29(32):5260-6. (PMID: 21609747)
Biochim Biophys Acta Biomembr. 2018 Aug;1860(8):1589-1599. (PMID: 29856994)
Drug Discov Today. 2017 Jan;22(1):166-172. (PMID: 27713035)
Int J Biol Macromol. 2018 Jul 1;113:534-542. (PMID: 29408613)
Food Chem. 2018 Jan 15;239:268-275. (PMID: 28873569)
J Control Release. 1999 Nov 1;62(1-2):231-8. (PMID: 10518655)
Mol Pharm. 2011 Dec 5;8(6):2358-67. (PMID: 21905667)
J Mater Chem B. 2014 Feb 14;2(6):616-619. (PMID: 32261277)
Biotechnol Adv. 2014 Nov 15;32(7):1269-1282. (PMID: 25099657)
Mol Pharm. 2015 Aug 3;12(8):2947-61. (PMID: 26149889)
J Control Release. 1998 Mar 2;52(1-2):1-16. (PMID: 9685931)
J Pharm Pharmacol. 1990 Dec;42(12):821-6. (PMID: 1983142)
J Mater Chem B. 2018 Jan 28;6(4):593-601. (PMID: 32254488)
Pharm Res. 1996 Dec;13(12):1838-45. (PMID: 8987081)
Nat Rev Drug Discov. 2003 Apr;2(4):289-95. (PMID: 12669028)
Int J Pharm. 2015 Jul 15;489(1-2):277-84. (PMID: 25957702)
Eur J Pharm Biopharm. 2014 Oct;88(2):518-28. (PMID: 24968819)
Int J Pharm. 2013 Aug 16;452(1-2):233-40. (PMID: 23688622)
Drug Dev Ind Pharm. 2019 Sep;45(9):1403-1420. (PMID: 31215293)
Biopolymers. 2008;90(3):213. (PMID: 18428153)
Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):179-86. (PMID: 25349046)
Int J Biol Macromol. 2018 Nov;119:413-422. (PMID: 30048728)
J Control Release. 2007 Sep 26;122(2):141-50. (PMID: 17707540)
Adv Drug Deliv Rev. 2011 Oct;63(13):1118-59. (PMID: 21855584)
Adv Drug Deliv Rev. 2007 Jul 30;59(7):667-76. (PMID: 17618704)
Pharm Res. 2014 May;31(5):1099-105. (PMID: 24185592)
Diabetes Technol Ther. 2020 Jan;22(1):10-18. (PMID: 31436480)
Int J Nanomedicine. 2011;6:1155-66. (PMID: 21822379)
Lancet. 1976 Oct 16;2(7990):824-7. (PMID: 61498)
Nanomedicine (Lond). 2011 Feb;6(2):365-75. (PMID: 21385138)
Cell Mol Life Sci. 2013 Feb;70(4):631-59. (PMID: 22782113)
Vaccine. 2001 Oct 12;20(1-2):208-17. (PMID: 11567766)
ACS Nano. 2015 Mar 24;9(3):2345-56. (PMID: 25658958)
Biomaterials. 2010 Apr;31(12):3384-94. (PMID: 20149435)
Pharm Res. 2007 Dec;24(12):2198-206. (PMID: 17577641)
Eur J Pharm Biopharm. 2017 Jun;115:257-267. (PMID: 28336368)
Am J Clin Nutr. 2009 Sep;90(3):822S-825S. (PMID: 19571229)
Drug Target Insights. 2007;2:71-81. (PMID: 21901064)
Chem Rev. 2017 Jun 28;117(12):8094-8128. (PMID: 28541045)
J Bone Miner Res. 2012 Aug;27(8):1821-9. (PMID: 22437792)
Crit Rev Ther Drug Carrier Syst. 2007;24(2):147-202. (PMID: 17725524)
فهرسة مساهمة: Keywords: ASBT, apical sodium-dependent bile acid transporter; BSA, bovine serum albumin; CAGR, compound annual growth; CD, Crohn's disease; COPD, chronic obstructive pulmonary disease; CPP, cell penetrating peptide; CaP, calcium phosphate; Clinical; DCs, dendritic cells; DDVAP, desmopressin acetate; DTPA, diethylene triamine pentaacetic acid; EDTA, ethylene diamine tetraacetic acid; EPD, empirical phase diagrams; EPR, electron paramagnetic resonance; Enzyme inhibitor; FA, folic acid; FDA, U.S. Food and Drug Administration; FcRn, Fc receptor; GALT, gut-associated lymphoid tissue; GI, gastrointestinal; GIPET, gastrointestinal permeation enhancement technology; GLP-1, glucagon-like peptide 1; GRAS, generally recognized as safe; HBsAg, hepatitis B surface antigen; HPMCP, hydroxypropyl methylcellulose phthalate; IBD, inflammatory bowel disease; ILs, ionic liquids; LBNs, lipid-based nanoparticles; LMWP, low molecular weight protamine; MCT-1, monocarborxylate transporter 1; MSNs, mesoporous silica nanoparticles; NAC, N-acetyl-l-cysteine; NLCs, nanostructured lipid carriers; Oral delivery; PAA, polyacrylic acid; PBPK, physiologically based pharmacokinetics; PCA, principal component analysis; PCL, polycarprolacton; PGA, poly-γ-glutamic acid; PLA, poly(latic acid); PLGA, poly(lactic-co-glycolic acid); PPs, proteins and peptides; PVA, poly vinyl alcohol; Peptides; Permeation enhancer; Proteins; RGD, Arg-Gly-Asp; RTILs, room temperature ionic liquids; SAR, structure–activity relationship; SDC, sodium deoxycholate; SGC, sodium glycocholate; SGF, simulated gastric fluids; SIF, simulated intestinal fluids; SLNs, solid lipid nanoparticles; SNAC, sodium N-[8-(2-hydroxybenzoyl)amino]caprylate; SNEDDS, self-nanoemulsifying drug delivery systems; STC, sodium taurocholate; Stability; TAT, trans-activating transcriptional peptide; TMC, N-trimethyl chitosan; Tf, transferrin; TfR, transferrin receptors; UC, ulcerative colitis; UEA1, ulex europaeus agglutinin 1; VB12, vitamin B12; WGA, wheat germ agglutinin; pHPMA, N-(2-hydroxypropyl)methacrylamide; pI, isoelectric point; sCT, salmon calcitonin; sc, subcutaneous
تواريخ الأحداث: Date Created: 20210915 Latest Revision: 20240403
رمز التحديث: 20240403
مُعرف محوري في PubMed: PMC8424290
DOI: 10.1016/j.apsb.2021.04.001
PMID: 34522593
قاعدة البيانات: MEDLINE
الوصف
تدمد:2211-3835
DOI:10.1016/j.apsb.2021.04.001